BIOREGENX, INC. (BRGX) Total liabilities 2021–2025
BIOREGENX, INC. (BRGX) total liabilities at each fiscal year-end, per SEC filings.
$4.9MFY2025 · since FY2021: $211,996 → $4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.9M | +27.3% |
| FY2024 | $3.9M | +32.4% |
| FY2023 | $2.9M | +1026.7% |
| FY2022 | $260,691 | +23.0% |
| FY2021 | $211,996 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Gross marginBRGX Operating incomeBRGX Operating marginBRGX Operating cash flowBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Shareholders’ equityBRGX overview →